Explore evidence-based treatment approaches for premature ejaculation, from behavioural techniques and medical therapies to the latest advances in andrological care.
Premature ejaculation (PE) is one of the most common male sexual health concerns, affecting a significant proportion of men at some point in their lives. The International Society for Sexual Medicine defines PE as a condition characterised by ejaculation that occurs within approximately one minute of vaginal penetration, though the exact time threshold can vary depending on individual circumstances and expectations. The condition is further defined by the inability to delay ejaculation on all or nearly all vaginal penetrations, and the presence of negative personal consequences such as distress, frustration, or avoidance of sexual intimacy.
The prevalence of premature ejaculation varies across different studies, with research suggesting that between 20% and 30% of men experience PE symptoms at some stage in their lives. This makes it the most frequently reported male sexual dysfunction, surpassing even erectile dysfunction in younger men. The condition can manifest in two primary forms: lifelong (primary) PE, which has been present since the first sexual experience, and acquired (secondary) PE, which develops after a period of normal sexual function. Understanding this distinction is essential for determining the most appropriate treatment pathway.
The impact of premature ejaculation extends far beyond the physical aspects of sexual activity. Men experiencing PE often report significant psychological distress, including feelings of embarrassment, inadequacy, and loss of self-confidence. These emotional consequences can create a cycle of performance anxiety that further exacerbates the condition. The effects ripple through relationships as well, with partners potentially experiencing frustration, reduced sexual satisfaction, and emotional disconnection. Studies have shown that PE can significantly diminish quality of life, affecting not just intimate relationships but also general psychological wellbeing and self-esteem.
Despite its prevalence and significant impact, many men remain reluctant to seek professional help for premature ejaculation. This hesitation often stems from embarrassment, lack of awareness about available treatments, or the mistaken belief that nothing can be done. However, the medical community now recognises PE as a treatable condition with multiple effective interventions available. Understanding the causes of premature ejaculation is the first step towards finding an appropriate solution, and modern andrology offers a comprehensive range of treatment options tailored to individual needs and circumstances.
Behavioural techniques represent one of the cornerstone approaches in managing premature ejaculation, particularly for men with lifelong PE or those whose condition has a significant psychological component. These methods focus on increasing awareness of arousal levels and developing greater control over the ejaculatory reflex. The stop-start technique, developed by Dr James Semans in the 1950s, involves stimulation until the point just before ejaculation, then pausing until arousal subsides before resuming. This method helps men recognise the sensations preceding ejaculation and learn to modulate their response.
The squeeze technique, refined by Masters and Johnson, offers another practical approach. When approaching the point of ejaculatory inevitability, firm pressure is applied to the head of the penis for several seconds, reducing arousal and postponing ejaculation. With consistent practice, these techniques can help recondition ejaculatory responses and extend the duration of sexual activity. Many specialists recommend combining these methods with partner involvement, as collaborative practice can reduce performance pressure whilst strengthening intimate communication and connection.
Psychological interventions play a vital role in addressing the mental and emotional factors contributing to premature ejaculation. Cognitive behavioural therapy (CBT) has demonstrated effectiveness in treating PE by helping men identify and modify thought patterns that contribute to performance anxiety and rapid ejaculation. Through CBT, individuals learn to challenge catastrophic thinking, reduce anticipatory anxiety, and develop healthier perspectives on sexual performance. Sex therapy, whether individual or couple-based, addresses relationship dynamics, communication barriers, and any underlying psychological issues that may be maintaining the condition.
Mindfulness-based approaches have gained recognition as valuable tools in managing premature ejaculation. These techniques encourage present-moment awareness during sexual activity, helping men shift focus away from performance concerns and towards pleasurable sensations. By reducing anxiety and increasing body awareness, mindfulness can interrupt the cycle of worry and rushed performance that often characterises PE. Pelvic floor exercises, commonly known as Kegel exercises, strengthen the muscles involved in ejaculatory control and have shown promise in extending ejaculatory latency time when performed regularly over several months.
Pharmacological interventions have transformed the treatment landscape for premature ejaculation, offering effective options for men who do not achieve sufficient improvement with behavioural techniques alone. Selective serotonin reuptake inhibitors (SSRIs), originally developed as antidepressants, have emerged as the most extensively studied medical treatment for PE. These medications work by increasing serotonin levels in the brain, which has the effect of delaying ejaculation. Dapoxetine, a short-acting SSRI specifically licensed for treating premature ejaculation in the UK, can be taken on-demand one to three hours before sexual activity.
Daily SSRI therapy using medications such as paroxetine, sertraline, or fluoxetine has demonstrated significant efficacy in extending intravaginal ejaculatory latency time (IELT), with some studies reporting increases of three to eight-fold compared to baseline. The ejaculation-delaying effect typically develops over one to two weeks of regular use, reaching optimal effectiveness after two to three weeks. Whilst SSRIs are generally well-tolerated, potential side effects include nausea, fatigue, decreased libido, and erectile difficulties in some men. These considerations make it essential to work with a qualified healthcare professional to determine the most appropriate medication and dosage.
Topical anaesthetic agents offer another pharmacological approach by temporarily reducing penile sensitivity. Lidocaine-prilocaine cream or spray can be applied to the glans penis approximately 20 to 30 minutes before sexual activity, then washed off prior to penetration. These preparations work by numbing the most sensitive areas, thereby delaying ejaculation. Some men prefer this on-demand approach as it avoids systemic medication effects, though care must be taken to prevent transfer of the anaesthetic to partners, which could reduce their sensation. Combination approaches, using both topical agents and behavioural techniques, often yield superior results compared to either method alone.
Phosphodiesterase-5 (PDE5) inhibitors, commonly known for treating erectile dysfunction, may also benefit some men with premature ejaculation, particularly when PE co-exists with erectile concerns. Medications such as sildenafil, tadalafil, and vardenafil can help men feel more confident about maintaining erections, potentially reducing performance anxiety that contributes to rapid ejaculation. Additionally, these medications may have a direct effect on ejaculatory control through mechanisms that are still being studied. Tramadol, an atypical opioid analgesic, has shown promise in treating PE in research settings, though it is not currently licensed for this indication in the UK and carries risks of dependence and other side effects.
For men who do not achieve satisfactory results with conventional treatments, advanced andrological interventions provide additional options. Hyaluronic acid injection into the glans penis represents an innovative approach that has gained attention in recent years. This procedure involves injecting hyaluronic acid dermal filler beneath the skin of the glans to increase its volume and reduce sensitivity. The theory behind this treatment is that by creating a cushioning layer beneath the glans epithelium, nerve endings become less responsive to stimulation, thereby delaying ejaculation whilst preserving pleasurable sensation. It is widely considered for cases of life-long premature ejaculation cases.
The hyaluronic acid glans augmentation procedure is performed as an outpatient treatment under local anaesthesia. The specialist andrologist carefully injects small amounts of hyaluronic acid filler at multiple points around the glans to achieve uniform distribution and natural appearance. The procedure typically takes between 30 and 45 minutes, with most men able to return to normal activities within a day or two. Sexual activity can usually resume after approximately one week, once any initial swelling has subsided. The hyaluronic acid gradually integrates with the tissue, providing longer-lasting results compared to topical treatments.
Clinical studies examining the effectiveness of hyaluronic acid glans augmentation for premature ejaculation have shown encouraging results. Research published in peer-reviewed urology journals has reported significant improvements in intravaginal ejaculatory latency time following the procedure. One study involving 60 men with lifelong PE found that glans augmentation increased average IELT from under one minute to over three minutes at six-month follow-up, with high patient satisfaction rates. Another investigation reported that approximately 70% of treated men experienced clinically meaningful improvements in ejaculatory control that persisted beyond 12 months. Whilst individual results vary, many men report not only extended duration but also increased sexual confidence following treatment.
Moorgate Andrology offers hyaluronic acid glans augmentation as part of their comprehensive approach to treating premature ejaculation. The clinic's experienced urologists have expertise in performing this procedure with precision and attention to achieving natural-looking results whilst maximising functional benefits. The treatment is conducted in a discreet, professional environment with full aftercare support to ensure optimal outcomes. As with all medical procedures, a thorough consultation is essential to determine suitability, discuss realistic expectations, and ensure that this approach aligns with the individual's specific circumstances and treatment goals. The hyaluronic acid used is biocompatible and gradually metabolised by the body over time, though effects typically last 12 to 18 months or longer before any maintenance treatment might be considered.
Effective management of premature ejaculation requires a personalised approach that considers the individual's specific circumstances, the type and severity of PE, any co-existing conditions, relationship factors, and personal preferences. Specialist urologists and andrologists bring essential expertise to this process, conducting comprehensive assessments that go beyond symptom reporting to explore underlying causes and contributing factors. A detailed medical and sexual history helps distinguish between lifelong and acquired PE, identify psychological components, and detect any medical conditions that might be contributing to the problem.
The assessment process typically includes discussion of intravaginal ejaculatory latency time, though specialists recognise that subjective distress and impact on quality of life are equally important considerations. Physical examination may be conducted to rule out anatomical abnormalities or conditions such as prostatitis or hyperthyroidism that can contribute to ejaculatory difficulties. Validated questionnaires and assessment tools help quantify the severity of symptoms and their impact on sexual satisfaction and relationships. This thorough evaluation enables the specialist to recommend the most appropriate treatment pathway, whether that involves behavioural techniques, pharmacological intervention, advanced procedures, or a combination of approaches.
Moorgate Andrology's approach to treating premature ejaculation exemplifies the importance of specialist care in achieving optimal outcomes. The clinic's GMC-registered urologists combine extensive experience with a commitment to evidence-based practice, ensuring that recommendations align with the latest clinical research. Patients benefit from private, discreet consultations where concerns can be discussed openly without embarrassment. The treatment philosophy emphasises realistic expectations, informed decision-making, and ongoing support throughout the treatment journey. Whether pursuing behavioural modification, medication, hyaluronic acid augmentation, or combination therapy, patients receive expert guidance tailored to their individual needs.
Follow-up care represents an essential component of successful PE treatment. Regular review appointments allow the specialist to assess treatment effectiveness, make adjustments as needed, and address any concerns that arise. For men undergoing hyaluronic acid glans augmentation or other procedures, structured aftercare ensures proper healing and optimal results. The relationship between patient and specialist evolves into a therapeutic partnership focused on restoring sexual confidence and enhancing intimate wellbeing. This comprehensive, personalised approach distinguishes specialist andrology care from generic solutions and significantly improves the likelihood of achieving lasting improvements in ejaculatory control and sexual satisfaction.
As understanding of premature ejaculation continues to evolve, so too do the available treatment options. Ongoing research into the neurobiological mechanisms underlying PE may yield new pharmacological targets, whilst refinements in procedural techniques continue to improve outcomes for advanced interventions. What remains constant is the recognition that premature ejaculation is a legitimate medical condition deserving of professional attention and effective treatment. Men experiencing PE should feel encouraged to seek help from qualified specialists who can offer the expertise, discretion, and comprehensive care needed to address this common but often distressing condition. With the right support and treatment approach, significant improvement in ejaculatory control and sexual wellbeing is achievable for the vast majority of men affected by premature ejaculation.
About Moorgate Andrology
Moorgate Andrology is a UK-based Specialist clinic providing penis enlargement surgery, penile fillers and peyronies disease management.
Treatments are delivered using a medically-led approach focused on safety, precision and natural-looking results